http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0417029-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
filingDate 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3e3996816d3af3dbd66635f38d2024
publicationDate 2007-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0417029-A
titleOfInvention 7- [4- (4-chlorobenzyloxy) benzenesulfonyl] -8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleto or tosylate as antipsychotic
abstract "7- ¢ 4- (4-Chlorobenzyloxy) benzenesulfonyl! -8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine as an antipsychotic". The present invention relates to novel salts of 7 ¢ 4- (4-chlorobenzyloxy) benzenesulfonyl-8-methoxy-3-methyl2,3,4,5-tetrahydro-1H-3-benzazepine and its pharmaceutically acceptable solvate, pharmaceutical formulations , processes for their preparation and their use in medicine. Chemical entities are usable in therapy, in particular as antipsychotic agents.
priorityDate 2003-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429285847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456405831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153805601

Total number of triples: 20.